International Journal of Applied Pharmaceutics (Int J App Pharm) is a peer-reviewed, bimonthly (onward March 2017) open access journal devoted to the ...
the international journal of pharmaceutics is the second most cited journal in the pharmaceutical sciences field out of 168 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, …
16.11.2021 · Journal of Applied Pharmaceutical Science ISSN The ISSN of Journal of Applied Pharmaceutical Science is 22313354. ISSN stands for International Standard Serial Number. An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
16.11.2021 · International Journal of Applied Pharmaceutics Rank and SCImago Journal Rank (SJR) The overall rank of International Journal of Applied Pharmaceutics is 17272 . According to SCImago Journal Rank (SJR), this journal is ranked 0.238. SCImago Journal Rank is an indicator, which measures the scientific influence of journals.
The Impact Factor of this journal is 6.598, ranking it 24 out of 275 in Pharmacology & Pharmacy; With this journal indexed in 3 international databases, ...
Journal of Applied Pharmaceutical Science (JAPS) is a monthly, international, open access, journal dedicated to various disciplines of pharmaceutical and ...
International Journal of Applied Pharmaceutics International Journal of Applied Pharmaceutics (Int J App Pharm) is a peer-reviewed, bimonthly (onward march 2017) open access journal devoted to the excellence and research in the pure pharmaceutics.
International Journal of Applied Pharmaceutics. Country. India ... Publisher. International Journal of Applied Pharmaceutics. H-Index. 15. Publication type. Journals. ISSN. 09757058. Coverage. 2011-2020. Scope Information not localized Join the ... The users of Scimago Journal & Country Rank have the possibility to dialogue through comments ...